14 results
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
Person reasonably determines that having common counsel would present such counsel with a conflict of interest or if the defendant in, or target of, any
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
. No FINRA member participating in the offering has a conflict of interest with the Company. For this purpose, a “conflict of interest” exists when
8-K
EX-10.2
HEPA
Hepion Pharmaceuticals Inc
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
, and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent
8-K
EX-1.1
HEPA
Hepion Pharmaceuticals Inc
12 Feb 20
Entry into a Material Definitive Agreement
4:55pm
to the indemnifying party, (3) a conflict or potential conflict of interest exists (based on advice of counsel to the indemnified party) between
10-KT
EX-14.1
e3nm2i
26 Mar 18
Annual report (with FYE transition)
12:00am
DEF 14A
xxwdacvwp1 cfn
27 Oct 14
Definitive proxy
12:00am
PRER14A
k4kj5
23 Oct 14
Preliminary revised proxy
12:00am
10-12G
EX-3.2
xbrtuc3akjhum6c0 x3
8 Aug 13
Registration of securities
12:00am
- Prev
- 1
- Next